Skip to main content

GLENVIEW CAPITAL MANAGEMENT, LLC

Position in BSX — Boston Scientific Corp

CIK 1138995 NEW YORK, NY

Position in BSX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,826,937
-$1,649,222 QoQ
Shares Held
113,096
-32.4% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#423
of 1,464 holders
Holding Since
Mar 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BSX Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

GLENVIEW CAPITAL MANAGEMENT, LLC holds $140,703,630 across 3 Medical Devices names. BSX ranks #3 (3.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 BSX
Boston Scientific Corp
This page
113,096 $4,826,937

All Filings in BSX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,826,937 113,096
2022-09-30 $6,476,159 167,213
2022-06-30 $33,371,408 895,396
2022-03-31 $61,325,218 1,384,629
2021-12-31 $46,672,096 1,098,684
2021-09-30 $89,526,456 2,063,297
2021-06-30 $99,332,164 2,323,016
2021-03-31 $123,601,385 3,197,966
2020-12-31 $97,168,571 2,702,881
2020-09-30 $39,931,436 1,045,052
2020-06-30 $74,187,465 2,113,001
2020-03-31 $77,915,839 2,387,859